ArticleFrontiers in neuroscience2026
Bridging engineering and neuro-oncology: a scalable FastAPI-deployed CNN framework for real-time explainable brain tumor diagnosis.
Article in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Capturing fine-grained spatial details in brain tumor MRI via multi-module feature enhancement.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Automated and interpretable classification of brain tumors from MRI scans remains a critical challenge in medical imaging and neuro-oncology. This study addresses the need for reliable and deployable AI-driven tools that support timely tumor differentiation while maintaining transparency and practical usability. Methods: A deep learning-based diagnostic framework was developed using convolutional neural networks implemented in TensorFlow. The system was trained and evaluated on a curated dataset of 3,097 axial brain MRI images spanning four classes: glioma, meningioma, pituitary tumor, and normal cases. To ensure robust performance estimation, all models were evaluated using stratified 5-fold cross-validation and benchmarked against multiple state-of-the-art transfer learning architectures. For real-world applicability, the selected models were deployed via a FastAPI-based server, and Gradient-weighted Class Activation Mapping (Grad-CAM) was incorporated to provide qualitative visual explanations. Results: Across cross-validation folds, the proposed framework demonstrated stable and competitive performance in terms of accuracy, macro-averaged F1-score, and macro-averaged AUC, with low inter-fold variance. Comparative evaluation showed that transfer learning models achieved strong classification performance, while the lightweight custom CNN remained suitable for real-time deployment. The FastAPI implementation enabled low-latency inference and on-demand Grad-CAM visualizations, supporting transparent and responsive model usage. Conclusion: This work demonstrates the feasibility of bridging deep learning-based brain tumor classification with scalable, real-time deployment. By combining robust cross-validation, state-of-the-art benchmarking, and explainability-aware inference, the proposed framework provides a practical pathway toward integrating artificial intelligence into radiological workflows, while highlighting the importance of interpretability and deployment constraints in neuro-oncological applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.